top of page
Dr. Kate Baker on the BackTable Tumor Board Podcast

Dr. Kate Baker

Medical Oncologist

2 Podcasts on BackTable

Dr. Kate Baker is a medical oncologist and Medical Director of Value-Based Care at Tennessee Oncology.

Learn from the experiences and expertise of Dr. Kate Baker and other leading voices in your specialty on the BackTable app.

Antibody Drug Conjugates Across the HER2 Spectrum: From HER2-Positive to Ultralow Breast Cancer
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 52  •  24 Mar 2026

Antibody Drug Conjugates Across the HER2 Spectrum: From HER2-Positive to Ultralow Breast Cancer

Antibody-drug conjugates (ADCs) are expanding treatment options in breast cancer, but their use requires careful attention to toxicity. In this episode of the BackTable Tumor Board Podcast, Dr. Kate Baker and Dr. Sara Nunnery review the role of ADCs in HER2-positive disease and their growing application in HER2-low and HER2-ultralow metastatic settings.

More from Dr. Kate Baker

Loading recent podcasts…

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page